Cell Reports Medicine

  • Home
  • Cell Reports Medicine

Cell Reports Medicine Broad-scope open access journal from Cell Press publishing cutting-edge science across the spectrum

29/05/2025

Online now: Effect of complete, lifelong ANGPTL3 deficiency on triglyceride-rich lipoprotein kinetics

http://dlvr.it/TL3Pwh

29/05/2025

Online now: Distinct viral reservoirs and immune signatures in individuals on long-term antiretroviral therapy with perinatally acquired HIV-1

http://dlvr.it/TL3GQg

28/05/2025

Online now: Contrastive functional connectivity defines neurophysiology-informed symptom dimensions in major depression

http://dlvr.it/TL2Dm8

27/05/2025

Online now: CD97-directed CAR-T cells with enhanced persistence eradicate acute myeloid leukemia in diverse xenograft models

http://dlvr.it/TL1KpD

27/05/2025

Online now: Minimally invasive diagnosis of precancerous cervical lesions using single-cell peripheral immune atlas

http://dlvr.it/TL19qY

27/05/2025

Online now: DDX5 super-enhancer promotes vasculogenic mimicry formation and metastasis in nasopharyngeal carcinoma by enhancing ADAM10 transcription

http://dlvr.it/TL15GM

26/05/2025

Online now: Tumor immune microenvironment delineates progression trajectories of distinct nasopharyngeal carcinoma phenotypes

http://dlvr.it/TL0HbS

26/05/2025

Online now: Benmelstobart plus anlotinib and chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: A phase 2 study

http://dlvr.it/TL08mG

26/05/2025

Online now: Cross-species tropism of AAV.CPP.16 in the respiratory tract and its gene therapies against pulmonary fibrosis and viral infection

http://dlvr.it/TL04p1

23/05/2025

Online now: White matter fractional anisotropy decreases precede hyperintensities in Alzheimer’s disease

http://dlvr.it/TKxxHh

23/05/2025

Online now: Felicia Pagliuca: Dr. Felicia Pagliuca is currently Senior Vice President, Cell and Genetic Therapy Research at Vertex Pharmaceuticals. She received a BS from Duke University and a PhD from Cambridge University where she was a Marshall Scholar. She completed her postdoctoral fellowship with Dr. Douglas Melton at the Harvard Stem Cell Institute, where she worked with Dr. Melton to discover how to generate stem cell-derived pancreatic beta cells in the lab. She co-founded Semma Therapeutics with Dr. Melton in 2014.

http://dlvr.it/TKxnbm

23/05/2025

Online now: Targeting STING antagonism in HSV-1: A peptide-based strategy to restore antiviral immunity and suppress viral pathogenesis: Herpes simplex virus 1 (HSV-1) poses significant threats to human health. Wang et al. show that the HSV-1 protein directly antagonizes STING. A designed peptide derived from stimulator of interferon genes (STING) can restore virus-subverted immunity and inhibit HSV-1 replication and pathogenesis in mice.

http://dlvr.it/TKxjVS

Address


Website

Alerts

Be the first to know and let us send you an email when Cell Reports Medicine posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Cell Reports Medicine:

Shortcuts

  • Address
  • Alerts
  • Contact The Business
  • Claim ownership or report listing

  • Want your business to be the top-listed Media Company?

Share

Our Mission

To foster deeper engagement and crosstalk between the translational and clinical research communities and increase the reach and visibility of research that can positively impact human health.

We publish original research that ranges from exciting concepts in human biology, health, and disease to all phases of clinical work. We encourage innovative ideas that open up new directions in clinical research and practice, as well as studies that provide critical information that enriches our understanding of current standards of care in diagnosis, treatment, and prognosis.